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The bifunctional flavoenzyme proline utilization A (PutA)
catalyzes the two-step oxidation of proline to glutamate using
separate proline dehydrogenase (PRODH) and L-glutamate-␥semialdehyde dehydrogenase active sites. Because PutAs catalyze sequential reactions, they are good systems for studying
how metabolic enzymes communicate via substrate channeling.
Although mechanistically similar, PutAs vary widely in domain
architecture, oligomeric state, and quaternary structure, and these
variations represent different structural solutions to the problem
of sequestering a reactive metabolite. Here, we studied PutA from
Corynebacterium freiburgense (CfPutA), which belongs to the
uncharacterized 3B class of PutAs. A 2.7 Å resolution crystal structure showed the canonical arrangement of PRODH, L-glutamate␥-semialdehyde dehydrogenase, and C-terminal domains, including an extended interdomain tunnel associated with substrate
channeling. The structure unexpectedly revealed a novel open conformation of the PRODH active site, which is interpreted to represent the non-activated conformation, an elusive form of PutA that
exhibits suboptimal channeling. Nevertheless, CfPutA exhibited
normal substrate-channeling activity, indicating that it isomerizes
into the active state under assay conditions. Sedimentation-velocity experiments provided insight into the isomerization process,
showing that CfPutA dimerizes in the presence of a proline analog
and NADⴙ. These results are consistent with the morpheein model
of enzyme hysteresis, in which substrate binding induces conformational changes that promote assembly of a high-activity oligomer. Finally, we used domain deletion analysis to investigate the
function of the C-terminal domain. Although this domain contains
neither catalytic residues nor substrate sites, its removal impaired
both catalytic activities, suggesting that it may be essential for
active-site integrity.
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The proline catabolic pathway consists of two enzymes that
catalyze the 4-electron oxidation of L-proline to L-glutamate
(Fig. 1). The flavoenzyme proline dehydrogenase (PRODH)4
catalyzes the FAD-dependent oxidation of L-proline to the
cyclic imine ⌬1-pyrroline-5-carboxylate (P5C). Hydrolysis of
P5C generates the open-chain aldehyde, L-glutamate-␥semialdehyde (GSAL), which is the substrate for the second
enzyme of the pathway, GSAL dehydrogenase (GSALDH).
GSALDH (also known as P5CDH) is an aldehyde dehydrogenase superfamily (ALDHSF) enzyme (also known as
ALDH4A1) that catalyzes the NAD⫹-dependent oxidation
of GSAL to L-glutamate.
Proline catabolism has emerged as an interesting system for
studying the communication between enzymes in metabolic
pathways. In some bacteria, PRODH and GSALDH are combined into the bifunctional enzyme proline utilization A (PutA)
(1). The covalent linking of the two enzymes suggests a direct
mechanism of communication via substrate channeling. Indeed, kinetic studies have shown that PutAs exhibit substrate
channeling (2– 8). Crystal structures of PutAs showed the basis
for substrate channeling; the two active sites are connected by a
tunnel through which the intermediate travels (2, 3, 6, 8). The
very existence of PutA suggested the hypothesis that substrate
channeling might also occur in organisms where PRODH and
GSALDH are distinct enzymes encoded by separate genes, as in
eukaryotes and some bacteria. This hypothesis was validated
recently for Thermus thermophilus PRODH and GSALDH (9).
Thus, the available data suggest that communication between
PRODH and GSALDH via substrate channeling is a conserved
aspect of proline catabolism.
PutAs are also useful for exploring multidomain protein
structure. Although all PutAs catalyze the aforementioned
reactions using highly conserved active sites, they are surprisingly diverse in terms of domain architecture, sequence simi4

The abbreviations used are: PRODH, proline dehydrogenase; P5C, ⌬1-pyrroline-5-carboxylate; GSAL, L-glutamate-␥-semialdehyde; GSALDH, L-glutamate-␥-semialdehyde dehydrogenase; ALDHSF, aldehyde dehydrogenase superfamily; PutA, proline utilization A; BjPutA, B. japonicum proline
utilization A; GsPutA, G. sulfurreducens proline utilization A; SmPutA,
S. meliloti proline utilization A; EcPutA, E. coli proline utilization A; CfPutA,
C. freiburgense proline utilization A; PDB, Protein Data Bank; THFA, L-tetrahydrofuroic acid; THP, Tris(hydroxypropyl)phosphine; oAB, ortho-aminobenzaldehyde; BisTris, 2-[bis(2-hydroxyethyl)amino]-2-(hydroxymethyl)
propane-1,3-diol.
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Figure 1. The reactions of proline catabolism.

Figure 2. Classification and diversity of PutAs. A, the three domain architectures of PutAs. B, phylogenetic tree based on global sequence alignments of
PutAs. PutAs with architecture types A, B, and C are indicated by black, blue, and red type, respectively. The four PutAs for which crystal structures have been
obtained are listed in large type. The alignments were calculated with Clustal Omega (56) and visualized with DrawTree (57). C, structures of PutA oligomers that
have been validated by crystallography and SAXS (PDB codes 4NMA, 3HAZ, and 5KF6).

larity, oligomeric state, and quaternary structure. Three PutA
domain architectures (A, B, and C) are known (Fig. 2A) (1, 10,
11). Type A PutAs have the minimal set of domains consisting
of N-terminal PRODH and C-terminal GSALDH modules (Fig.
2A). Type B and C PutAs have an additional ALDHSF domain
following the GSALDH module. The function of this domain is
a subject of this report. Finally, type C PutAs have an N-terminal ribbon-helix-helix DNA-binding domain. Type C PutAs are
unique in the PutA family in that they regulate transcription of
the put regulon, which contains the genes encoding PutA and
the proline transporter PutP (12–14). The ribbon-helix-helix
domain plays an essential role in the gene regulatory function
by binding to multiple operator sites located between the divergently transcribed putA and putP genes.
Sequence alignments reveal another layer of diversity. The
PutA phylogenetic tree has three main branches (Fig. 2B). The
pairwise sequence identities between PutAs from different

branches are typically ⬃30%, suggesting substantial differences. Paradoxically, the branches do not correspond exactly to
the three domain architectures described above. In fact, all
three architectures are represented in branch 1, whereas
branch 2 contains only type A PutAs, and branch 3 contains
only type B PutAs.
Combining the domain architectures with phylogeny yields
five PutA classes designated by the branch number and domain
architecture type: 1A, 1B, 1C, 2A, and 3B. This scheme differs
slightly from an older one in which 2A and 3B PutAs were
grouped in the same branch of the tree (1, 10). Crystal structures are available for the 1A PutA from Bradyrhizobium
japonicum (BjPutA) (2), the 2A PutA from Geobacter sulfurreducens (GsPutA) (6), and the 1B PutA from Sinorhizobium
meliloti (SmPutA) (8). Also, structures of the PRODH (15–18)
and DNA-binding domains (13, 14) of the 1C PutA from Escherichia coli (EcPutA) have been determined.
J. Biol. Chem. (2017) 292(23) 9652–9665
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Table 1
Kinetic parameters for wild-type and mutant CfPutA
Activity

Enzyme

Variable substrate

Km

kcat

⫺1 ⫺1
M
s

145 ⫾ 16 mM

2.6 ⫾ 0.1

54 ⫾ 6 M

1.7 ⫾ 0.1

17.9 ⫾ 0.1
0.20 ⫾ 0.02a
0.20 ⫾ 0.02a
32,000 ⫾ 5,000

s

PRODH
GSALDH
a

Wild type
S916*
Y927*
Wild type

Proline
Proline
Proline
P5C

kcat/Km

⫺1

Calculated from line of best fit over three data points (Fig. 3A).

The diversity of PutAs extends to oligomeric state and quaternary structure. Type A PutAs form domain-swapped dimers
(2, 6), and in at least one case (BjPutA), two of the dimers assemble into a ring-shaped tetramer (2) (Fig. 2C). Type B PutAs are
monomeric (4) or exist as a concentration-dependent monomer-dimer equilibrium (8), with the dimer having a completely
different quaternary structure from type A dimers (Fig. 2C).
Type C PutAs form a third distinct type of dimer, which is
mediated by the DNA-binding domain (19).
As part of our exploration of PutA structural diversity, we
targeted 3B PutAs for analysis. Herein, we report the first structure of a class 3B PutA along with solution oligomeric state
studies, kinetic characterization of substrate channeling, and
domain deletion analysis probing the role of the C-terminal
ALDHSF domain. The structure of the 3B PutA from Corynebacterium freiburgense (CfPutA) exhibits novel features, including an unexpected FAD conformation and extensive conformational disorder, resulting in a highly open PRODH active
site. Sedimentation-velocity data show that CfPutA dimerizes
in the presence of active-site ligands, identifying CfPutA as
a potential morpheein enzyme. Transient time analysis and
intermediate trapping assays are consistent with a substratechanneling mechanism. Deletion of the C-terminal ALDHSF
domain abrogates both catalytic activities, suggesting that it is
essential for maintaining the integrity of the active sites. The
results further highlight the diversity of the PutA family and
provide insight into structural basis of hysteretic substrate
channeling.

Results
Steady-state kinetic characterization of the PRODH and
GSALDH activities of CfPutA
Purified CfPutA is a yellow solution, consistent with a flavoenzyme. The extent of FAD incorporation into the protein
was determined. The extinction coefficient of CfPutA䡠FAD was
experimentally estimated to be 13,100 M⫺1 cm⫺1. Measurement of the flavin spectrum after size exclusion chromatography indicated 0.3 mol of FAD/mol of CfPutA (30% incorporation). This value is lower than other PutAs, which have FAD
incorporation ranging from 60% (20) to ⬎ 80% (7, 21, 22).
The steady-state kinetic parameters describing the PRODH
activity were measured using the dichlorophenolindophenol
assay. When proline is the variable substrate, the kinetic parameters are Km of 145 mM and kcat of 2.6 s⫺1, which corresponds to
a catalytic efficiency (kcat/Km) of 18 M⫺1 s⫺1 (Table 1 and Fig.
3A). The PRODH catalytic efficiency of CfPutA is on the low
end for PutAs, which have reported values of 30 – 400 M⫺1 s⫺1
(4, 20, 22–24).
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Figure 3. Steady-state kinetics data. A, dependence of PRODH activity on
proline concentration. B, dependence of GSALDH activity on P5C concentration. For both panels, results are shown for wild-type CfPutA (black squares),
CfPutA S916* (red triangles), and CfPutA Y927* (blue triangles). Fits to the
Michaelis-Menten equation for wild-type CfPutA are represented by the red
curves. Linear regression was used for the mutant variants to guide the eye and to
estimate kcat/Km for PRODH activity. Analysis was done using Origin 2016.

The GSALDH activity of CfPutA using P5C as the variable
substrate revealed a Km of 54 M and a kcat of 1.7 s⫺1, corresponding to a catalytic efficiency of 32,000 M⫺1 s⫺1 (Table 1 and
Fig. 3B). For reference, the kcat/Km values of other PutAs span
the range of 4800 –214,000 M⫺1 s⫺1 (4, 6). Thus, the GSALDH
activity of CfPutA is not unusual.
Structure of CfPutA
Homolog screening of five class 3B PutAs identified CfPutA
as amenable to crystal structure determination. The crystal
structure of CfPutA was determined at 2.7 Å resolution in space
group P1 (Table 2). It is the first structure of a class 3B PutA and
the second of a PutA containing the C-terminal ALDHSF
domain. Other PutAs represented in the PDB share ⬍ 30%
sequence identity with CfPutA. Because of the low sequence
identity to other PutAs, molecular replacement required the
use of a search model based on a monofunctional GSALDH
with only 33% identity to CfPutA over 415 residues (see “Experimental procedures”).

Class 3B proline utilization A
Table 2
Data collection and refinement statistics
Values for the outer resolution shell of data are given in parentheses. RMSD, root mean square deviation.
Triclinic

a
b
c

Trigonal

Space group

P1

P3121

Unit cell parameters
Å
Degrees
Wavelength
Resolution (Å)
Observations
Unique reflections
Rmerge(I)
Rmeas(I)
Rpim(I)
Mean I/
Mean CC1⁄2
Completeness (%)
Multiplicity

a ⫽ 85.0, b ⫽ 116.4, c ⫽ 140.7
␣ ⫽ 71.5, ␤ ⫽ 89.7, ␥ ⫽ 83.4
1.000
63.29 to 2.70 (2.75 to 2.70)
260,275 (12,837)
137,220 (6798)
0.058 (0.488)
0.082 (0.689)
0.058 (0.485)
8.3 (1.7)
0.994 (0.620)
98.5 (98.1)
1.9 (1.9)

a ⫽ 145.6, c ⫽ 214.3

No. of atoms
Protein
FAD
NAD⫹
Sulfate ion
Rwork
Rfreea
RMSD bond lengths (Å)
RMSD bond angles (degrees)

29,652
29,280
212
140
20
0.183 (0.273)
0.236 (0.349)
0.009
1.053

Ramachandran plotb
Favored (%)
Outliers (%)
Clashscore (PR)b
MolProbity score (PR)b

97.20
0.00
5.05 (100)
1.68 (100)

Average B-factor (Å2)
Protein
FAD ⫹
NAD
Sulfate ion
Coordinate error (Å)c
PDB entry

51.5
56.0
60.3
74.1
0.38
5UX5

1.000
63.07 to 3.30 (3.43 to 3.30)
434,766 (44,854)
40,228 (4491)
0.177 (1.224)
0.186 (1.291)
0.056 (0.406)
14.4 (2.1)
0.997 (0.742)
100.0 (100.0)
10.8 (10.8)

5% test set.
From MolProbity. The percentile ranks (PR) for Clashscore and MolProbity score are given in parenthesis.
Maximum likelihood-based coordinate error estimate reported by phenix.refine.

Despite the low sequence identity to other PutAs, CfPutA
resembles other PutAs in both the folds and spatial arrangement of the catalytic modules (Fig. 4A). For example, analysis of
the PDB with PDBeFold (25) identified GsPutA (31% identical)
as the closest structural neighbor of CfPutA, with a root mean
square deviation of 1.8 Å over 941 residues. The similarity of
CfPutA to SmPutA (27% identity) is lower, with a root mean
square deviation of 2.6 Å over 1208 residues.
Like other PutAs, CfPutA contains a PRODH module in the
N-terminal half of the polypeptide chain and a GSALDH module in the C-terminal half (Fig. 4A). The core of the PRODH
module is a distorted (␤␣)8 barrel (residues 130 – 420) containing the FAD bound at the C termini of the strands of the barrel.
The GSALDH module features the two-domain architecture
common to all ALDHs. The GSALDH module consists of a
Rossmann fold NAD⫹-binding domain (residues 475– 689 and
891–908) and an ␣/␤ catalytic domain (residues 690 – 890),
which contains catalytic Cys-723.
As in other PutAs, the PRODH and GSALDH active sites of
CfPutA are separated by a linear distance of 45 Å and connected
by a curved tunnel that traverses 65 Å and ranges in radius from
1.5 to 4.5 Å (Fig. 4A). The dimensions of the tunnel are consistent with those found in other PutA structures, such as SmPutA
(Fig. 4B).

CfPutA also has a domain following the GSALDH module
(Fig. 2A). This domain was previously called the C-terminal
domain of unknown function, but here we use the term
ALDHSF domain in reference to the recently discovered structural similarity to ALDHs (8).
The C-terminal ALDHSF domain (residues 909 –1069) consists of an ␣/␤ subdomain and protruding ␤-flap (Fig. 5A). The
␣/␤ subdomain resembles the Rossmann dinucleotide-binding
domain, yet it does not bind NAD⫹ in CfPutA or SmPutA. The
␤-flap resembles the oligomerization domain found in many
ALDHs, but it does not mediate oligomerization in CfPutA or
SmPutA. Instead, the ␤-flap appears to facilitate substrate
channeling by covering a large section of the tunnel that connects the two active sites, thereby preventing leakage of the
intermediate (Fig. 4).
The ALDHSF domains of CfPutA and SmPutA differ in two
respects. First, whereas the ␣/␤ subdomain of SmPutA is
a complete Rossmann domain consisting of five parallel ␤strands and three ␣-helices (Fig. 5B), CfPutA has an abbreviated Rossmann fold, which lacks ␤3 and its flanking helices
(Fig. 5A). Second, the CfPutA ALDHSF domain has an extra
␤-strand at its N terminus, which forms an interdomain twostranded antiparallel ␤-sheet with the NAD⫹-binding domain
(Fig. 5A).
J. Biol. Chem. (2017) 292(23) 9652–9665
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Figure 4. Structure of the CfPutA monomer and comparison to SmPutA. A, backbone and surface representations of CfPutA. The domains have different
colors, with the N-terminal arm in orange, PRODH barrel in cyan, PRODH-GSALDH linker in violet, GSALDH NAD⫹-binding in red, GSALDH catalytic in blue, and
C-terminal ALDHSF in gold. The silver surface represents the substrate-channeling tunnel. The FAD is shown in yellow sticks. The dotted lines indicate disordered
residues 33–118 (␣-domain) and 421– 434 (which connect ␣8 to the PRODH-GSALDH linker). The sites of domain deletion mutations are indicated as 916* and
927*. B, backbone and surface representations of SmPutA. The domains are colored as in A. The ␣-domain, which is disordered in CfPutA, is colored green.

Disorder in the PRODH module
The CfPutA structure is unique for what is unobserved. Electron density for residues 33–118 and 421– 434 was very weak in
all four chains in the crystallographic asymmetric unit and prevented the inclusion of these residues in the structure (Fig. 4A,
dotted lines).
Residues 33–118 correspond to the ␣-domain, which is a
bundle of 4 – 6 ␣-helices in other PutAs. As shown for SmPutA,
the ␣-domain contacts the PRODH barrel, GSALDH catalytic
domain, and ALDHSF ␤-flap (Fig. 4B). Thus, the ␣-domain may
be a coupling domain that helps maintain the proper spacing
and orientation of the two active sites.
The second disordered section (residues 421– 434) is the
beginning of the linker that connects the PRODH barrel to the
GSALDH module (Fig. 4A). The disordered section starts just
after helix ␣8 of the PRODH barrel. Helix ␣8 is notable because
it contains several conserved residues that interact with the
substrate proline in the Michaelis complex (6, 16, 26) Furthermore, ␣8 has been shown to move in response to proline binding, giving rise to open (proline-free) and closed (prolinebound) PRODH conformations (6, 26).
Because of the disordered sections, the PRODH site of
CfPutA is more open and the FAD is more exposed than in
other PutAs (Fig. 4). For example, the reactive surface of the

9656 J. Biol. Chem. (2017) 292(23) 9652–9665

isoalloxazine (si face) is visible in a surface rendering of CfPutA
(Fig. 4A) and hidden in SmPutA (Fig. 4B). Analysis by
PDBePISA shows the solvent-accessible surface area of the
FAD in CfPutA is 179 Å2, which corresponds to 19% of the total
area of the free FAD. Thus, the FAD is 81% buried in CfPutA.
For comparison, the FAD is 92% buried in the PRODH-open
state of GsPutA (PDB code 4NM9) and 95% buried in PRODHclosed states of GsPutA and SmPutA (PDB codes 4NMA and
5KF6; Fig. 4B). Thus, the CfPutA structure reveals a new, more
open conformation of the PutA PRODH active site.
New FAD conformation
The FAD in CfPutA has an unexpected conformation, which
could be related to the disorder in the surrounding protein. The
ribityl 2⬘-OH group is under the pyrimidine ring of the isoalloxazine, whereas the 3⬘-OH is directed toward the FAD ribose,
and the 4⬘-OH sits under the dimethylbenzene ring (Fig. 6A). In
this conformation, the 2⬘-OH donates a hydrogen bond to the
FAD N1 atom, whereas the 3⬘-OH forms a hydrogen bond with
the FAD ribose. Curiously, this ribityl conformation is diagnostic of the 2-electron-reduced FAD in PutA (Fig. 6B) (6, 18), yet
reducing agent was not added during crystallization of CfPutA
or cryoprotection of the crystals. We note the ribityl conformation expected for the oxidized PutA FAD is clearly different

Class 3B proline utilization A

Figure 5. Comparison of the C-terminal ALDHSF domains of CfPutA and SmPutA. A, the ALDHSF domain of CfPutA. The truncation points for the S916* and
Y927* C-terminal deletion mutants are marked by arrowheads. B, the ALDHSF domain of SmPutA. In both panels, the diagram shows the topology of the
Rossmann fold part of the ALDHSF domain.

mation of a reduced PutA FAD, whereas the isoalloxazine conformation is indicative of an oxidized FAD.
Oligomeric state in solution

Figure 6. Unexpected FAD conformation. A, 2.7 Å resolution electron density for the FAD in CfPutA. The cage represents a simulated annealing
A-weighted Fo ⫺ Fc omit map (3.0). The inset shows an edge-on view of the
isoalloxazine ring. B, superposition of the FAD in CfPutA (yellow) and the
2-electron-reduced FAD in GsPutA (gray). The inset shows an edge-on view of
the isoalloxazine ring. Note that the two FADs have the same ribityl conformation but different butterfly bend angles. C, a typical oxidized PutA FAD
(from GsPutA). Note that the ribityl conformation differs from that in B.

(Fig. 6C). Interestingly, bona fide PutA FAD reduction results in
strong butterfly bending of the isoalloxazine ring system (Fig.
6B, inset). Electron density suggests the isoalloxazine of CfPutA
is planar, indicative of the oxidized state (Fig. 6A, inset). In
summary, the FAD in CfPutA exhibits the ribityl chain confor-

Sedimentation-velocity experiments were performed on
CfPutA to further investigate whether the oligomeric state is
conserved across type B PutAs. A sedimentation-velocity study
conducted at 0.8 mg/ml (6.7 M) revealed one major peak with
an apparent sedimentation coefficient of 4.4 S, corresponding
to ⬃129 kDa (Fig. 7A). This molecular mass is within 8% of the
predicted mass of a CfPutA monomer of 119 kDa.
A sedimentation-velocity experiment was performed at the
higher concentration of 6 mg/ml (50 M) to check for concentration-dependent oligomerization, as found with SmPutA (8).
This analysis also revealed a primary peak at 4.35 S corresponding to ⬃130 kDa (Fig. 7B). Taken together, these sedimentation-velocity results suggest that CfPutA is primarily monomeric under the conditions used.
Crystal structure data are consistent with the sedimentationvelocity results. Analysis of protein-protein interfaces in the P1
crystal lattice with PDBePISA revealed no stable assemblies.
The largest interface is a two-body assembly formed by chains
A and B, which has an interfacial area of 1100 Å2 (Fig. 8A). For
reference, the validated dimer of SmPutA (also a type B PutA)
J. Biol. Chem. (2017) 292(23) 9652–9665
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Figure 7. Sedimentation-velocity analysis of CfPutA in the absence of
active-site ligands. A, sedimentation coefficient and molecular mass distributions for CfPutA at 0.8 mg/ml (7 M). B, sedimentation coefficient and
molecular mass distributions for CfPutA at 6 mg/ml (50 M).

has an interface area of 1800 Å2 (Fig. 8C). Similarly, the crystal
packing in a low-resolution trigonal CfPutA crystal form (Table
2) implies no stable interfaces; the largest interface in that crystal form buries 1050 Å2 (Fig. 8B). Furthermore, the two CfPutA
crystal forms do not share a common assembly, and the
SmPutA dimer is not present in either CfPutA lattice. All of
these observations are consistent with CfPutA being predominantly monomeric under the solution conditions used in centrifugation and crystallization.

Figure 8. Dimeric assemblies of CfPutA and SmPutA. A, the largest proteinprotein interface in the CfPutA P1 crystal form. B, the largest protein-protein
interface in the CfPutA trigonal crystal form. C, the bona fide dimer of SmPutA,
which has been validated by SAXS and crystallography (PDB code 5KF6). The
interfacial surface areas are listed for each assembly. On the left side, the
chains have different colors. On the right side, the domains are colored as in Fig.
4: N-terminal arm (orange), ␣-domain (green), PRODH barrel (cyan), PRODHGSALDH linker (violet), NAD⫹-binding (red), GSALDH catalytic (blue), and
C-terminal ALDHSF (gold).

Ligand-induced protein dimerization
CfPutA was crystallized with NAD⫹ in the GSALDH active
site and the PRODH proline site unoccupied. We hypothesized
that the lack of a PRODH ligand could be responsible for the
unprecedented level of disorder observed in the crystal structure near the PRODH active site. To explore this idea, we investigated the solution properties of CfPutA using the proline
analog L-tetrahydro-2-furoic acid (THFA), a well-known competitive inhibitor of PRODHs (6, 8, 16, 23, 26). Surprisingly,
these studies suggest that THFA may enhance dimerization of
CfPutA.
Sedimentation-velocity experiments were used to monitor
ligand-induced self-association. Ligand-free CfPutA analyzed
at the relatively high protein concentration of 50 M (6 mg/ml)
showed a single peak corresponding to the monomer (Fig. 9,
top). In the presence of the THFA (10 mM) and NAD⫹ (1 mM),
a second peak is visible corresponding to a species with an
apparent sedimentation coefficient of 5.5–5.6 S. As the protein
concentration is raised from 14 to 84 M, the secondary peak

9658 J. Biol. Chem. (2017) 292(23) 9652–9665

Figure 9. CfPutA undergoes concentration-dependent oligomerization
in the presence of active-site ligands. Sedimentation-velocity experiments
were performed at the indicated CfPutA concentrations in the absence (top
panel) or presence (bottom four panels) of the proline analog THFA (10 mM)
and NAD⫹ (1 mM).

grows while the monomer peak diminishes (Fig. 9, bottom four
panels). At 84 M, the peak with the larger apparent sedimentation coefficient (⬃5.5 S) corresponds to a molecular mass of
232.6 kDa, which is within 2% of the theoretical mass of a dimer
(238.5 kDa). Overall, these data suggest the oligomeric state of
CfPutA in solution is influenced by both the occupancy of the
proline substrate site and protein concentration.
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Figure 11. Deletion of the ALDHSF domain does not result in apparent
destabilization of CfPutA tertiary structure. Thermal shift assay melt
curves are shown for wild-type CfPutA (black), CfPutA S916* (red), and CfPutA
Y927* (blue). The horizontal black dashed line represents 0.5 of the total fraction unfolded. The three vertical dashed lines indicate the T0.5 of each protein.
The plotted curves are the average of samples measured in triplicate normalized to fraction unfolded.

Taken together, the P5C-trapping assays and transient time
analysis suggest that CfPutA exhibits substrate channeling.
The C-terminal ALDHSF domain is necessary for PRODH and
GSALDH activity
Figure 10. Evidence for substrate channeling in CfPutA. A, P5C-oAB-trapping experiments performed in the absence (solid lines) or presence (dashed
lines) of NAD⫹. B, transient-time analysis of CfPutA. Experimental data from a
PRODH-GSALDH-coupled assay are represented in solid black. A non-channeling model calculated from Equation 1 is represented in orange. The dotted
black line represents extrapolation of the predicted steady-state rate to estimate a transient time of 1.2 min.

CfPutA exhibits a substrate-channeling mechanism
The observation of a tunnel in the structure motivated studies of substrate channeling. To test whether CfPutA is capable
of substrate channeling, a P5C trapping assay was employed.
This experiment monitors the formation of a yellow conjugate
formed between the intermediate P5C and ortho-aminobenzaldehyde (oAB). Experiments performed in the absence of NAD⫹
provide the upper limit for the build up of P5C in the bulk
solvent. Conversely, experiments performed in the presence of
NAD⫹ should show reduced P5C-oAB conjugate formation if
P5C moves to the GSALDH active site without leaving the
enzyme. Results of this assay on CfPutA show a 52% decrease in
steady-state P5C-oAB conjugate formation in the presence of
NAD⫹, consistent with substrate channeling (Fig. 10A).
To further investigate whether CfPutA channels substrate,
production of NADH was monitored after the addition of proline to determine whether a lag phase occurs, indicative of a
non-channeling system (transient time analysis). For wild-type
CfPutA, the production of NADH versus time is approximately
linear with no substantial lag phase (Fig. 10B). The transient
time, , for two non-interacting enzymes can be estimated from
the free-diffusion model in Equation 1. The calculated theoretical value of  for CfPutA is 1.2 min (Fig. 10B). A lag time of this
magnitude is not evident in the experimental data, which is
consistent with a substrate-channeling mechanism (Fig. 10B).

Although the structure of the C-terminal ALDHSF domain is
now known for two PutAs, its functions have not been fully
determined. To gain insight into the functions of this domain,
two domain deletion mutants were generated by introducing
premature stop codons at Ser-916 (S916*) or Tyr-927 (Y927*)
(Fig. 5A).
Because domain deletion is dramatic, a fluorescencemonitored thermal shift assay was used to qualitatively assess
whether deletion of the C-terminal domain affects the thermostability of the protein. Wild-type CfPutA displayed an average
T0.5 of 47.6 ⫾ 0.1 °C (range of 47.5– 47.7 °C; Fig. 11). CfPutA
S916* and Y927* mutants displayed a similar unfolding profile
with T0.5 values of 48.4 ⫾ 0.2 °C (range of 48.1– 48.6 °C) and
48.9 ⫾ 0.2 °C (range of 48.7– 49.2 °C), respectively (Fig. 11).
This result suggests that the C-terminal truncation mutants
display apparent thermostability similar to that of the wild-type
protein, consistent with similarly folded proteins. Overall, the
thermal shift assay results suggest that the C-terminal domain
truncation mutants probably retain significant native structure.
Steady-state kinetic assays were performed with both truncation mutant variants. PRODH activity was severely decreased
in both. Saturation with proline was not possible, indicating a
very high Km (Fig. 3A). Estimation of kcat/Km using the linear
approximation suggested a 100-fold decrease in catalytic efficiency (Table 1). The impact of the deletion on GSALDH activity was more severe; neither mutant displayed perceptible
GSALDH activity under the same reaction conditions as wild
type (Fig. 3B).

Discussion
Our report brings the number of PutA structures to four (Fig.
2B). All three branches are now represented in the PDB, and
J. Biol. Chem. (2017) 292(23) 9652–9665

9659

Class 3B proline utilization A
only the class 1C structure remains unsolved in its full-length
form (Fig. 2A). However, the catalytic part of 1C PutA should
be very similar to that of SmPutA, based on the high sequence
identity (60%) and the fact that the 1C EcPutA PRODH module
structure has the conserved (␤␣)8 barrel fold described here
(15).
This catalogue of structures reveals features conserved by the
entire PutA family. Although sequence identity between PutAs
can be as low as 30%, we now see that the folds of the catalytic
modules and dimensions of the intervening tunnel are highly
conserved. Also, the two type B PutA structures reveal a shared
fold for the C-terminal ALDHSF domain, although the branch
3 ALDHSF domain has a somewhat abbreviated Rossmann
subdomain (Fig. 5).
Interestingly, the Conserved Domain Database of NCBI (27),
as implemented in BLASTP (28), fails to recognize the C-terminal domain of CfPutA as an ALDHSF domain. Presumably,
this is due to the absence of Rossmann ␤-strand 3 and its flanking helices (Fig. 5A). Nevertheless, the crystal structure supports annotation of the C-terminal domain of CfPutA as an
ALDHSF domain. In conclusion, the C-terminal domains of
both class 1B and 3B PutAs exhibit the ALDHSF fold (Fig. 5).
The C-terminal ALDHSF domain is the least understood
PutA domain, because it contains neither catalytic residues nor
substrate-binding sites. We showed here that the ALDHSF
domain of CfPutA is critical for both PRODH and GSALDH
functions. Essentiality of the ALDHSF domain for GSALDH
activity is consistent with the fact that the domain makes intimate contact with the GSALDH module (Fig. 4). Its importance
for PRODH activity is more surprising. Because deletion of the
ALDHSF domain in CfPutA nearly eliminates PRODH activity,
the ALDHSF domain must play a role in promoting the activity of the PRODH active site, presumably by stabilizing the
PRODH module via tertiary structural interactions. We note
the ALDHSF ␤-flap does make significant contacts with the
PRODH barrel (Fig. 4A).
Comparison of type A and B PutA structures reveals an interesting example of structural mimicry whereby the quaternary
structure of one protein (type A PutA) resembles the tertiary
structure of another protein (type B PutA). As described previously for SmPutA, the ␤-flap of the C-terminal ALDHSF
domain of type B PutA is structurally similar to the oligomerization flap of type A PutAs (8). In the type B PutA monomer, the
ALDHSF ␤-flap contacts both the PRODH barrel and the
GSALDH catalytic domain and also forms a lid that seals
the substrate-channeling tunnel (Fig. 4). We showed here using
domain deletion analysis that these interactions are apparently
needed for both catalytic functions. In type A PutAs, a conserved domain-swapped dimer interface provides analogous
structural interactions, thereby enabling catalytic activity in
both active sites and substrate channeling in the absence of the
ALDHSF domain.
Although CfPutA has the conserved PutA fold, it has unique
local structural features. The FAD has an unexpected ribityl
conformation, and there is unprecedented in crystallo disorder
in the ␣- and PRODH-barrel domains, resulting in unusually
high exposure of the FAD. In contrast, the GSALDH module
and active site with NAD⫹ bound exhibited no disorder and
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could be completely modeled. Because the PRODH active site is
disassembled, we hypothesize that the crystal structure may
represent an inactive conformation.
Given the peculiarities of the CfPutA structure (disorder,
unusual FAD conformation), it is notable that the enzyme
exhibits normal catalytic properties, implying that the active
conformation is achieved in solution in the presence of substrates. These results may provide insight into the hysteretic
substrate-channeling mechanism of PutA. A previous study of
EcPutA showed that the substrate-channeling step is slowest
during the first turnover and speeds up 40-fold with subsequent
turnovers, implying that channeling is activated (5). Although
the structural basis for activation is unknown, it has been proposed that isomerization associated with ligand binding (most
likely proline) provokes conformational changes that assemble
the PRODH active site and seal leaky parts of the tunnel system
(5). The structure reported here could resemble PutA prior to
activation.
Importantly, biophysical analysis of CfPutA has expanded
the oligomeric diversity of PutA proteins. Previous studies
revealed a range of oligomeric states: a monomeric class 1B
PutA (4); three different types of dimers in PutA classes 2A (6),
1B (8), and 1C (19); and a tetrameric 1A PutA (2). A recent study
of SmPutA, another type B PutA, revealed the first concentration-dependent oligomerization of a PutA (8). Here, we
showed that CfPutA is primarily monomeric but is capable
of concentration-dependent dimerization in the presence of
active site-associated ligands. This result suggests that occupancy of the proline substrate site in the PRODH module may
encourage dimerization. This example would add to the list of
proteins that experience ligand-induced oligomerization.
The concept of ligand-induced changes in oligomerization is
not novel. For example, ligand-induced dimerization of human
phenylalanine hydroxylase, the enzyme that catalyzes the first
step in the L-phenylalanine to L-tyrosine biosynthetic pathway,
was recently reported (29). Further, multiple oligomeric states
of DegP, an E. coli periplasmic protease, ranging from a resting
hexamer to active higher-order oligomers, are observed in
response to various substrate-mimicking peptide fragments
(30). Likewise, substrate binding to the catalytic site of porphobilinogen synthase causes conformational changes in the monomeric enzyme allowing for preferential formation of a more
active octamer over the less active hexameric form (31). The
binding of the substrates to the AMP biosynthetic enzyme
adenylosuccinate synthetase decreases the dissociation constant for dimerization by several orders of magnitude (32). Also,
ligand-induced dimerization is thought to be a key mechanism
in the regulation of MERS coronavirus nsp5 protease activity
during virus infection (33). Overall, ligand-induced oligomerization evidently plays an important role in enzyme function,
regulation, and stability across kingdoms.
In several of these examples, ligand binding induces formation of a high-activity oligomer, a phenomenon referred to by
Jaffe (34, 35) as morpheein equilibrium. Interestingly, the morpheein concept has been used to explain enzyme hysteresis, a
form of allosteric regulation that occurs in at least one PutA (5).
Whether the morpheein behavior of CfPutA is related to the
hysteresis of substrate channeling remains to be investigated.
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It is not apparent whether ligand-induced dimerization is
specific to CfPutA, branch 3 PutAs, or architecture type B
PutAs in general. The other type B PutAs that have been studied
are either monomeric (4) or form a monomer-dimer equilibrium (8). Whether ligand binding similarly promotes oligomerization of these PutAs remains to be investigated, as is the
underlying functional significance of the phenomenon, vis-àvis hysteresis.
The quaternary structure of the ligand-bound CfPutA dimer,
which is currently unknown, may provide additional information regarding the role of the C-terminal ALDHSF domain. It is
clear from analysis of the crystal structures of both CfPutA and
SmPutA that the C-terminal ALDHSF domain provides a crucial seal for the tunnel necessary for substrate channeling (Fig.
4). Additionally, the SmPutA dimer shows a novel self-association not seen in any other PutA or ALDHSF enzyme (Fig. 2C). It
remains to be investigated whether the CfPutA dimer resembles the SmPutA dimer. If so, this dimer would probably be a
hallmark of type B PutAs.

Experimental procedures
Construct generation and site-directed mutagenesis
The gene encoding CfPutA (1074 residues), codon-optimized for expression in E. coli, was synthesized (Bio Basic Inc.)
in a pUC57 vector backbone. The synthetic construct includes
a 5⬘ NdeI restriction site, the coding sequence of an 8⫻ His tag,
a tobacco etch virus protease site in frame with the CfPutA
coding sequence, and a 3⬘ XhoI restriction site. For protein
expression, the construct was subcloned into the pET22b vector backbone.
The CfPutA C-terminal truncation constructs (S916* and
Y927*; see Fig. 5A) were generated by introduction of a premature stop codon by site-directed mutagenesis using the QuikChange II XL site-directed mutagenesis kit (Agilent).
Protein expression and purification
Protein expression vectors were transformed into BL21(DE3)
cells (Thermo Fisher Scientific) for protein expression. A 20-ml
overnight starter culture grown from a single colony was used
to inoculate 1 liter of LB supplemented with 100 g/ml ampicillin and 15 mM riboflavin. Cultures were shaken at 37 °C and
250 rpm until A600 ⬃ 0.8. The temperature was then shifted to
18 °C, and protein expression was induced with 0.5 mM isopropyl ␤-D-1-thiogalactopyranoside. Cultures were shaken overnight. The next day, the cells were pelleted; resuspended in a
buffer containing 50 mM Tris, pH 7.8, 300 mM NaCl, and 5%
(v/v) glycerol; quick-cooled in liquid nitrogen; and placed at
⫺80 °C for storage.
For purification, the cell suspension was thawed and lysed by
sonication in the presence of 0.5 mM phenylmethylsulfonyl fluoride and 0.1 mM FAD. Unbroken cells and cell debris were pelleted by centrifugation at 16,000 rpm for 1 h at 4 °C in an SS-34
rotor. The supernatant was then loaded onto a HisTrap HP
nickel-affinity column pre-equilibrated with 50 mM Tris, pH
7.8, 300 mM NaCl, and 5% (v/v) glycerol. Protein was eluted
with 300 mM imidazole. Fractions containing protein were
pooled and supplemented with 0.1 mM FAD and 0.5 mM
Tris(hydroxypropyl)phosphine (THP). The His tag was removed

by adding 1 mg of tobacco etch virus protease per 30 mg of
target protein, incubating for 2 h at 28 °C, and then dialyzing
overnight at 4 °C against buffer containing 50 mM Hepes, pH
7.8, 300 mM NaCl, and 5% (v/v) glycerol. The sample was then
passed over a HisTrap HP nickel-affinity column. The eluate
from the column was collected, supplemented with 0.1 mM
FAD, and dialyzed overnight at 4 °C against a buffer containing
50 mM Tris, pH 7.8, 0.5 mM EDTA, and 5% (v/v) glycerol.
The following day, the sample was further purified using a
HiTrap Q anion-exchange column. Protein was eluted with a
linear gradient of NaCl from 0 to 1 M. Fractions containing
CfPutA were pooled, supplemented with 0.1 mM FAD, and
loaded onto a Superdex 200 16-600 size-exclusion column in
the presence of 50 mM Tris, pH 7.8, 100 mM NaCl, 0.5 mM
EDTA, 1 mM THP, and 5% (v/v) glycerol. Fractions were pooled
and concentrated. Protein concentrations were estimated by
the bicinchoninic acid method (Pierce). For analytical ultracentrifugation analysis of ligand-free CfPutA, the protein was
concentrated and used immediately. For analytical ultracentrifugation analysis of the CfPutA䡠THFA䡠NAD⫹ complex, eluted
protein was supplemented with 0.2 mM FAD, 1 mM NAD⫹, and
10 mM THFA at pH 8.0 and dialyzed for 4 h with two buffer
exchanges against a buffer containing the same components.
For all other applications, including crystallization and steadystate kinetics, the protein was quick-cooled in liquid nitrogen in
PCR-strip tubes and stored at ⫺80 °C.
Crystallization of CfPutA complexed with NADⴙ in space
group P1
Homolog screening was performed in search of a 3B PutA
that was amenable to crystal structure determination. In addition to CfPutA, the PutAs from Helicobacter pylori, Helicobacter hepaticus, Corynebacterium jeikeium, and Cellulomonas
cellasea were screened. Only CfPutA was crystallizable.
Triclinic crystals of CfPutA were grown by sitting-drop
vapor diffusion at 20 °C. Sparse matrix screening using commercially available crystallization screens was conducted using
purified CfPutA concentrated to 12 mg/ml and supplemented
with 10 mM NAD⫹. The screens produced several crystallization hits in the form of microcrystals. Results from optimization
trials led to thin needles/plates grown in 0.2 M magnesium chloride hexahydrate, 0.1 M BisTris, pH 6.5, and 25% (w/v) polyethylene glycol (PEG) 3350. This condition was further optimized
by combining it with other crystal screen reagents, essentially
using the crystal screen kits as additive screens. The final crystallization reservoir was composed of 3 parts of solution A (0.2
M magnesium chloride hexahydrate, 0.1 M BisTris, pH 6.5, 25%
(w/v) PEG 3350) and 1 part of solution B (0.1 M HEPES, pH 7.5,
10% (w/v) PEG 6000, 5% (v/v) (⫾)-2-methyl-2,4-pentanediol).
The crystals were cryoprotected using the reservoir supplemented with 20% (v/v) PEG 200, picked up with nylon loops,
and quick-cooled in liquid nitrogen. Approximately 120 crystals were surveyed at beamline 4.2.2 of the Advanced Light
Source. Only one crystal diffracted significantly beyond 3.0 Å,
from which a 2.70 Å resolution data set was obtained for structure determination (Table 2). The space group is P1 with the
unit cell dimensions shown in Table 2. The asymmetric unit
contains four protomers, corresponding to a Matthews coeffiJ. Biol. Chem. (2017) 292(23) 9652–9665

9661

Class 3B proline utilization A
cient of 2.7 Å3/Da and 55% solvent (36). We note that surface
mutagenesis or the inclusion of THFA failed to improve crystallization of CfPutA.
Crystallization of CfPutA in space group P3121
The crystal screening trials also produced crystals shaped like
hexagonal bipyramids. These crystals were grown by sittingdrop vapor diffusion at 20 °C using CfPutA concentrated to 24
mg/ml. Crystals were obtained from a reservoir solution containing 0.5 M ammonium sulfate, 0.1 M sodium citrate tribasic
dihydrate, pH 5.6, and 1.0 M lithium sulfate monohydrate. The
crystals were cryoprotected in the crystallization reservoir
supplemented with 20% (v/v) (⫾)-2-methyl-2,4-pentanediol,
picked up with nylon loops, and quick-cooled by plunging into
liquid nitrogen. Approximately 80 crystals were surveyed at
beamline 4.2.2 of the Advanced Light Source. Although the
external morphology and typical crystal size of this form were
more promising than those of the P1 form, the diffraction was
limited to 3.3–3.5 Å resolution. A 3.3 Å resolution data set was
collected for the purpose of inspecting oligomeric assemblies.
The space group is P3121 with unit cell dimensions a ⫽ 146 Å
and c ⫽ 214 Å. The asymmetric unit contains one CfPutA monomer, which corresponds to a Matthews coefficient of 5.5 Å3/Da
and 78% solvent (36).
X-ray diffraction data collection, phasing, and refinement
X-ray diffraction data were collected on Advanced Light
Source beamline 4.2.2 at Lawrence Berkeley National Laboratory using a Taurus-1 detector in shutterless mode. All
data sets were integrated and scaled with XDS (37). Intensities were merged and converted to amplitudes with Aimless
(38). Data-processing statistics for the two crystal forms are
listed in Table 2.
Crystallographic phasing by experimental methods was
anticipated to be challenging because of the difficulty in reproducing diffraction quality crystals. Phasing by molecular
replacement was also challenging due to the low sequence
identity of CfPutA with other PutA structures in the PDB
(⬍30%). Nevertheless, phasing by molecular replacement
was attempted.
The amino acid sequence of CfPutA and the P1 structure
factor amplitudes were input to the BALBES automated
molecular replacement pipeline server (39). BALBES (version
1.0.0.Nov_16_2011) generated search models from the structures of BjPutA (PDB code 3HAZ), three bacterial GSALDHs
(PDB codes 1UZB, 3QAN, and 3RJL), human succinic semialdehyde dehydrogenase (PDB code 2W8N), the EcPutA PRODH
domain (PDB code 4O8A), and a few structures unrelated to
PutA. The best solution was obtained with 3QAN and had a
Q-factor of 0.55, and 85% probability of being correct. We note
that the sequence identity between 3QAN and CfPutA is only
33% over 415 residues, and the search model represented only
46% of CfPutA. Refinement of the molecular replacement solution using REFMAC (40) (as part of the BALBES pipeline) produced a model with Rwork of 0.46 and Rfree of 0.49.
The phases were improved by density modification and automated model building using PHENIX (41). The map coefficient
file from BALBES/REFMAC was input to phenix.autobuild
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for automated model building with density modification. The
transformations needed for non-crystallographic symmetry
averaging were calculated from the BALBES/REFMAC model
(phenix.autobuild input_ncs_file option). The BALBES/REFMAC model was not supplied as the starting model for automated model building, which required ab initio model building
in PHENIX. The resulting model from phenix.autobuild
included 3184 residues of an expected 4304 (74% complete) and
had Rwork of 0.26 and Rfree of 0.31. This model and the corresponding 2Fo ⫺ Fc map coefficients were input to phenix.
autobuild for a second round of automated building and density
modification (rebuild_in_place ⫽ True). The resulting model
had Rwork of 0.24 and Rfree of 0.31.
The second-generation autobuild model was the starting
point for several rounds of model building in COOT (42) and
refinement in PHENIX (43). Non-crystallographic symmetry
restraints were used during refinement. The B-factor model
consisted of TLS refinement (one group/chain) plus an isotropic B-factor for each non-hydrogen atom. FAD and NAD⫹
were modeled in all four chains with occupancies of 1.0.
Electron density for the nicotinamide of NAD⫹ was weak
and diffuse, so this group was not included in the deposited
structure. Disorder of the nicotinamide half of the cofactor
has been observed in other GSALDH structures (44 – 46).
Electron density maps also indicated the presence of a sulfate
ion in the aldehyde site of the GSALDH module. The ion was
included in all four chains at an occupancy of 1.0. The binding of sulfate to the aldehyde site has been observed in other
GSALDH structures (2, 45). Due to the moderate resolution,
water molecules were not modeled. Structure quality was
validated using MolProbity (47) and the PDB (48) validation
server. Refinement statistics for the final model are listed in
Table 2.
Phases for the P3121 data set were obtained by molecular
replacement with Phaser (49) using a search model consisting
of a monomer from the final P1 structure. A solution with loglikelihood gain of 9000 was obtained. Refinement in PHENIX
resulted in Rwork of 0.19 and Rfree of 0.22.
Analytical ultracentrifugation
Sedimentation-velocity experiments were performed at 20 °C
in a Beckman XL-I analytical ultracentrifuge using an An50Ti
rotor. Aliquots of protein and reference buffer were loaded into
a sedimentation-velocity cell equipped with a dual-sector charcoal-Epon centerpiece. The reference buffer used for studies of
the ligand-free protein was an eluted fraction lacking protein, as
determined by A280, obtained from size-exclusion chromatography of the protein sample. The reference buffer for centrifugation of CfPutA in the presence of active-site ligands was the
buffer from dialysis. Following a 2-h temperature equilibration,
the sample was centrifuged at 35,000 rpm. The radial distribution of the sample was monitored with Rayleigh interference
optics. Data were acquired at 2-min intervals for 300 radial
scans. The data set was analyzed globally to obtain the sedimentation coefficient (c(s)) and molecular mass (c(M)) distributions
using Sedfit (50).
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Steady-state kinetics

P5C intermediate trapping assays

Steady-state PRODH activities and apparent kinetic constants for CfPutA and CfPutA C-terminal truncations were
determined using dichlorophenolindophenol as the terminal
electron acceptor with phenazine methosulfate as a mediator
electron acceptor, as described previously (4). Kinetic constants
Km and kcat for proline were determined using fixed concentrations of protein (0.42– 0.50 M), excess FAD (20 M), dichlorophenolindophenol (75 M), and varying proline concentration
(0 –500 mM). PRODH kinetics assays were carried out in 20 mM
Tris buffer (pH 8.0, 10% (v/v) glycerol). Data were collected
using the cuvette port of a NanoDrop 2000c spectrophotometer (Thermo Fisher Scientific). Km and kcat were calculated by
fitting observed initial velocities to the Michaelis-Menten
equation (Origin 2016). The low activity of the C-terminal truncation mutants prohibited the determination of Km and kcat.
For these proteins, the apparent catalytic efficiency (kcat/Km)
was estimated by linear regression of rate data measured below
saturation (Origin 2016).
Steady-state GSALDH activity was measured in 50 mM
potassium phosphate buffer (pH 7.5, 600 mM NaCl) as
described previously (5) using enzyme (0.03– 0.04 M) and
⫹
DL-P5C (0 –2.76 mM) in the presence of 200 M NAD .
GSALDH activity was monitored by following NADH formation at 340 nm (⑀340 ⫽ 6200 M⫺1 cm⫺1). Data were collected
using a KC4TM plate reader (BioTek). Km and kcat were calculated by fitting observed initial velocities to the Michaelis-Menten equation (SigmaPlot version 12.0).
The coupled PRODH-GSALDH assay was carried out as
described previously (6). A fixed concentration of enzyme
(0.42– 0.50 M) was mixed with 0.1 mM menadione bisulfite, 0.2
mM NAD⫹, and 40 mM proline. The reaction was performed in
50 mM potassium phosphate buffer (pH 7.5, 25 mM NaCl).
Reduction of NAD⫹ was followed at 340 nm (⑀340 ⫽ 6200 M⫺1
cm⫺1) using the cuvette port of a NanoDrop 2000c spectrophotometer (Thermo Fisher Scientific). Spectral interference of
menadione bisulfite was subtracted from all curves by performing the assays in the presence and absence of NAD⫹, as
described for GsPutA (6).
The coupled PRODH-GSALDH assay can be used to detect
substrate channeling by comparing the observed progress
curve with a theoretical prediction for non-interacting PRODH
and GSALDH enzymes calculated from the free diffusion
model (Equation 1) (51, 52).

Substrate channeling was also assessed by chemical trapping
of the intermediate P5C by oAB (2, 9). oAB traps P5C as a
dihydroquinazolinium compound that can be detected by
absorbance at 443 nm (⑀443 ⫽ 2590 M⫺1 cm⫺1). A fixed concentration of enzyme (0.03– 0.04 M) was mixed with 0.1 mM menadione bisulfite, 4 mM oAB, and 40 mM proline in 20 mM Hepes
buffer (pH 7.5, 10 mM MgCl2). The absorbance was measured
using an Epoch2 plate reader (BioTek). The assay was conducted both in the presence of 0.2 mM NAD⫹ or the absence of
NAD⫹, with the latter experiment defining the upper limit for
P5C release in the absence of channeling.

关 NADH兴 ⫽ v1t ⫹ 共v1/v2兲 Km共e⫺v2t/Km ⫺ 1兲

(Eq. 1)

In this equation, t is time, v1 is the rate of PRODH activity
under the reaction conditions (1.03 M䡠min⫺1), and the terms
v2 and Km are the steady-state kinetic parameters for the
GSALDH activity of wild-type CfPutA (v2 ⫽ 43 M䡠min⫺1,
Km ⫽ 54 M). In the absence of substrate channeling, the transient time () to achieve steady-state production of NADH is
the ratio of the GSALDH kinetic parameters, Km/v2. If substrate
channeling occurs, the observed  will be smaller than the limiting value of Km/v2.

Measurement of flavin incorporation
The extinction coefficient of CfPutA䡠FAD was determined as
described previously (53) by measuring the absorption spectra
of CfPutA in the absence and presence of 0.5% (w/v) SDS. Incubation with 0.5% (w/v) SDS was performed for 1 h prior to
recording the UV-visible spectrum. All measurements were
performed in 0.1 M phosphate buffer, pH 7.0. Spectra were measured in a CARY 50 UV-visible spectrophotometer (Agilent) at
25 °C. The percentage of flavin incorporation was then determined from the concentration ratio of FAD-bound CfPutA to
total CfPutA.
Thermal shift assays
The melting temperatures of CfPutA and the C-terminal
truncation variants were measured in a QuantStudio version 3
real-time PCR system (Thermo Fisher Scientific). Proteins were
loaded into a MicroAmp 96-well optical plate (Thermo Fisher
Scientific) at a concentration of 0.5 mg/ml in a buffer containing 50 mM Tris, pH 7.8, 100 mM NaCl, 0.5 mM EDTA, 1 mM
THP, and 5% (v/v) glycerol. The protein solutions were diluted
1:1 with a 10⫻ solution of SYPRO Orange (Thermo Fisher Scientific; 5000⫻ stock in DMSO) in 50 mM Tris, pH 7.8, 100 mM
NaCl, 0.5 mM EDTA, 1 mM THP, and 5% (v/v) glycerol such that
the final reaction concentration of SYPRO Orange was 5⫻. The
plate was sealed with optical film and allowed to incubate in the
dark at 4 °C for 1 h prior to the experiment. The incubated plate
was subjected to a protocol in which the plate was heated from
4 to 95 °C in 0.5 °C steps with a 20-s hold following each step.
Data were exported using QuantStudio version 3 software and
then normalized using the minimum and maximum relative
fluorescence of the transition, as described previously (54), and
plotted in R (55).
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